US Edition
News from pme.ch
If you want to know if pme.ch is credible or reliable, look no further. We rank pme.ch as Unknown factuality. Find out more about our methodology here.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top pme.ch News
Business · SwitzerlandDeals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new drugs in Switzerland, the CEO of Swiss pharma giant Roche was quoted as saying on Saturday. Under the deals announced on Friday, drugmakers including Roche's U.S. unit Genentech will slash prices on drugs sold to the U.S. Medicaid program for low-income people.See the Story
Roche CEO points to higher future drug prices in Switzerland after US deal
56% Center coverage: 9 sources
